CJ Pharma on Monday announced the launch of its two therapeutic equivalent generic versions of Daiichi-Sankyo’s Olmetec – Olmeact (olmesartan medoxomil) and Olmeact Plus (olmesartan medoxomil/hydrochlorothiazide).
Olmeact is available here in different dosage strengths (10mg, 20mg, 40mg), while Olmeact Plus 20/12.5mg is on the market.
Since our drugs are cost-effective than our competito...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.